Interleukin-1 receptor antagonist protein
| GO Term | Evidence Code | Reference |
|---|---|---|
| fever generation | ||
| lipid metabolic process | ||
| acute-phase response | ||
| inflammatory response | ||
| inflammatory response |
| GO Term | Evidence Code | Reference |
|---|---|---|
| extracellular region | ||
| extracellular region | ||
| extracellular region | ||
| extracellular region | ||
| obsolete extracellular space |
|
|
| GO Term | Evidence Code | Reference |
|---|---|---|
| cytokine activity | ||
| interleukin-1 receptor binding | ||
| interleukin-1 receptor binding | ||
| interleukin-1, type I receptor binding | ||
| interleukin-1, type I receptor binding |
| Pathway Name | Organism |
|---|---|
| Interleukin-1 signaling | Mus musculus |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.5.0
Last updated: April 6, 2026